期刊文献+

结肠癌转移相关基因1在宫颈鳞癌中的表达及其与预后的关系 被引量:3

Expression of metastasis- associated in colon cancer- 1 (MACC1) in cervical carcinoma and its association with prognosis
下载PDF
导出
摘要 目的探讨结肠癌转移相关基因1(MACC1)在宫颈鳞癌组织中的表达,并分析其与预后的关系。方法采用免疫组织化学检测63例宫颈鳞癌组织和相对应的63例正常宫颈上皮组织中MACC1蛋白的表达,并分析其与临床病理学参数及预后的关系。结果 MACC1在宫颈鳞癌组织中阳性表达率(65.08%,41/63)显著高于正常宫颈上皮组织(23.81%,15/63),差异有统计学意义(P<0.05)。MACC1蛋白表达与患者的组织学分化、临床分期、浸润深度和淋巴结转移密切相关(P<0.05),但与患者年龄无关(P>0.05)。MACC1阳性表达的宫颈鳞癌患者存活时间明显短于MACC1阴性表达的宫颈鳞癌患者(P<0.05)。结论 MACC1与宫颈鳞癌的发生发展关系密切,其表达高低有望成为宫颈鳞癌恶性程度及预后的判定指标。 Objective To investigate the expression of metastasis - associated in colon cancer - 1 ( MACC1 ) in cervical carcinoma tissues and analyze its association with the prognosis. Methods Expression of MACC1 protein was detected by immuno - histochemistry in 63 samples of cervical carcinoma tissues and 63 samples of paired normal cervical epithelial tissues, and its associations with clinicopathological features and prognosis were also investigated. Results Positive expression ratio of MACC1 in cervical carcinoma tissues (65. 00% , 41/63) was significantly higher than that in normal cervical epithelial tissues (23.81% , 15/63, P 〈 0. 05 ). Expression of MACC1 protein was tightly associated with histological differentiation, clinical staging, invasion depth and lymph node metastasis of the patients with cervical carcinoma (P 〈0. 05), but not related to the age (P 〉 0. 05 ). Furthermore, the survival time of the patients with MACC1 at high level was significantly lower than those with MACC1 at low level (P 〈 0. 05 ). Conclusion MACC1 is closely associated with the occurrence and development of cervical carcinoma, and its expression level may be a predictor for malignant degree and prognosis of cervical carcinoma.
出处 《广东医学》 CAS CSCD 北大核心 2014年第24期3814-3816,共3页 Guangdong Medical Journal
基金 河南省人口和计划生育科学技术研究项目(编号:20121026)
关键词 结肠癌转移相关基因1 宫颈癌 临床病理学参数 预后 metastasis- associated in colon cancer1 cervical carcinoma clinicopathological features prog-nosis
  • 相关文献

参考文献16

  • 1STEIN U, WALTHER W, ARLT F, et al. MACC1, a newly identified key regulator of HGF - MET signaling, predicts colon cancer metastasis [ J]. Nat Med, 2009, 15 ( 1 ) : 59 - 67.
  • 2MIGLIORE C, MARTIN V, LEONI V P, et al. MiR - 1 downregula- tion cooperates with MACC1 in promoting MET overexpression in hu- man colon cancer[J]. Clin Cancer Res, 2012, 18(3) : 737 -747.
  • 3GALIMI F, TORTI D, SASSI F, et al. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal can- cer: response to met inhibition in patient xenografts and pathologic correlations[ J ]. Clin Cancer Res, 2011, 17 (10) : 3146 - 3156.
  • 4SHIRAHATA A, SHINMURA K, KITAMURA Y, et al. MACC1 as a marker for advanced colorectal carcinoma [ J 1. Anticancer Res, 2010, 30(7): 2689-2692.
  • 5SHIRAHATA A, SAKATA M, KITAMURA Y, et al. MACC 1 as a marker for peritoneal -disseminated gastric carcinoma[J]. Anti- cancer Res, 2010, 30(9) : 3441 -3444.
  • 6SHIRAHATA A, FAN W, SAKURABA K, et al. MACC 1 as a marker for vascular invasive hepatocellular carcinoma [ J 1. Anti- cancer Res, 2011, 31 (3) : 777 - 780.
  • 7SHIMOKAWA H, URAMOTO H, ONITSUKA T, et al. Overex- pression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence [ J ]. J Thorac Cardiovasc Surg, 2011, 141(4) : 895 -898.
  • 8KUESTER D, DAR A A, MOSKALUK C C, et al. Early involve- ment of death - associated protein kinase promoter hypermethyla- tion in the carcinogenesis of Barrett's esophageal adenoearcinoma and its association with clinical progression[ J]. Neoplasia, 2007, 9(3) : 236 -245.
  • 9KOKOSZYBSKA K, KRYBSKI J, RYCHLEWSKI L, et al. Un- expected domain composition of MACC1 links MET signaling and apoptosis[ J]. Acta Bioehim Pol, 2009, 56(2) : 317 -323.
  • 10STEIN U, DALHLMANN M, WALTHER W, et al. MACC1 - more than metastasis? Facts and predictions about a novel gene [J]. J Mol Med, 2010, 88(1): 11 -18.

二级参考文献21

  • 1钱和年,崔恒,魏丽惠,李小平.第16届FIGO会议纪要(妇科肿瘤)[J].中国妇产科临床杂志,2001,2(1):57-61. 被引量:2
  • 2Stein U,Walther W,Arlt F,et al.MACC1,a newly identified key regulator of HGF-MET signaling,predicts colon cancer metastasis[J].Nat Med,2009,15(1):59-67.
  • 3Shirahata A,Shinmura K,Kitamura Y,et al.MACC1 as a marker for advanced colorectal carcinoma[J].Anticancer Res,2010,30(7):2689-2692.
  • 4Shirahata A,Sakata M,Kitamura Y,et al.MACC 1 as a marker for peritoneal-disseminated gastric carcinoma[J].Anticancer Res,2010,30(9):3441-3444.
  • 5Shirahata A,Fan W,Sakuraba K,et al.MACC 1 as a marker for vascular invasive hepatocellular carcinoma[J].Anticancer Res,2011,31(3):777-780.
  • 6Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249.
  • 7Arlt F,Stein U.Colon cancer metastasis:MACC1 and Met as metastatic pacemakers[J].Int J Biochem Cell Biol,2009,41(12):2356-2359.
  • 8Shimokawa H,Uramoto H,Onitsuka T,et al.Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence[J].J Thorac Cardiovasc Surg,2011,141(4):895-898.
  • 9Huang Y,Zhang H,Cai J,et al.Overexpression of MACC1 and its significance in human breast cancer progression[J].Cell Biosci,2013,3(1):16.
  • 10Wang G,Kang MX,Lu WJ,et al.MACC1:a potential molecule associated with pancreatic cancer metastasis and chemoresistance[J].Oncol Lett,2012,4(4):783-791.

共引文献27

同被引文献17

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部